The FDA approved daraxonrasib (Rasonque), the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a ...

One in 5 adults with newly diagnosed moderate to severe plaque psoriasis maintained clear or almost-clear skin a full year ...

Medicare Part D changes, premium stabilization expiration, and a Bridge demonstration converge with rising GLP-1 demand and costs. Medicare Part D plans are running out of easy ways to absorb the cost ...

Clinicians outline fragmented obesity and diabetes care models, insurance-driven prescribing, and early results from Medicare ...

A major factor, Bhatnagar explained, is uncompensated labor. Women faculty frequently take on mentorship, teaching, and committee responsibilities that consume significant time but go unrecognized in ...

Authors noted that a grocery assistance benefit in commercial health plans was linked to fewer diabetes complications and ...

CMS is funding 138 grants worth $144M to expand rural mental health, maternal, and emergency care access across Alabama. "Alabama is serious about creating systematic changes through the ARHTP ...

The adjusted-for-multiple-primaries method integrates incidence with cancer-free survival, improving lifetime risk estimation beyond registry counts when multiple primary cancers and competing ...

The FDA cleared the first and only single-biomarker blood test for assessing amyloid pathology to rule in or rule out Alzheimer disease in adults aged 55 and older. 1 ...

The next episode in this series, 'Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge,' features the panelists advancing their conversation on Alzheimer's disease ...

The AACR roadmap spotlights LDCT screening, ctDNA MRD monitoring, and new NSCLC/SCLC therapies like DLL3 tarlatamab to close ...

Before nipaclaimab-aahu’s approval, there were no FDA-approved drugs specifically indicated for wAIHA. Treatment generally ...